Trial
NCT01836549
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pediatric Brain Tumor Consortium
Collaborators
National Cancer Institute (NCI)
Condition
Anaplastic Astrocytoma
Intervention
imetelstat sodium
Why stopped
Due to several intracranial hemorrhages and recommendation by the PBTC DSMB.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-20